[1]   J. Moses, G. F. Bonomo, D. E. Wenlund, T. S. Halldorddon and J. P. Connelly, “Actinomyces in Childhood,” Clinical Pediatrics, Vol. 42, No. 2, 1967, pp. 221-226.

[2]   D. Bennhoff, “Actinomycosis: Diagnostic and Therapeutic Considerations and a Review of 32 Cases,” The Laryngoscope, Vol. 94, No. 9, 1984, pp. 1198-1217.

[3]   G. F. Mabeza and J. Macfarlane, “Pulmonary Actinomycosis,” European Respiratory Journal, Vol. 21, No. 3, 2003, pp. 545-551. doi:10.1183/09031936.03.00089103

[4]   M. Kolditz, J. Bickhardt, W. Matthiessen, O. Holotiuk, G. Hoffken and D. Koschel, “Medical Management of Pulmonary Actinomycosis: Data from 49 Consecutive Cases,” Journal of Antimicrobial Chemotherapy, Vol. 63, No. 4, 2009, pp. 839-841. doi:10.1093/jac/dkp016

[5]   S. Chouabe, D. Perdu, G. Deslée, D. Milosevic, E. Marque and F. Lebargy, “Endobronchial Actinomycosis Associated with Foreign Body: Four Cases and a Review of the Literature,” Chest Journal, Vol. 121, No. 6, 2002, pp. 2069-2072. doi:10.1378/chest.121.6.2069

[6]   B. D. Sarodia, C. Farver, S. Erzurum and J. R. Maurer, “A Young Man with Two Large Lung Masses,” Chest Journal, Vol. 116, No. 3, 1999, pp. 814-818.

[7]   N. Shinagawa, E. Yamaguchi, Takahashi and M. Nishimura, “Pulmonary Actinomycosis Followed by Pericarditis and Intractable Pleuritis,” Internal Medicine, Vol. 41, No. 4, 2002, pp. 319-322. doi:10.2169/internalmedicine.41.319

[8]   M. Bennett and Dolin, “Principles and Practice of Infectious Diseases,” 6th Edition, Elsevier, Netherlands, 2005.

[9]   J. C. Choi, W. J. Koh, T. S. Kim, et al., “Optimal Duration of IV and Oral Antibiotics in the Treatment of Thoracic Actinomycosis,” Chest Journal, Vol. 128, No. 4, 2005, pp. 2211-2217. doi:10.1378/chest.128.4.2211